x-tention has acquired syndena for an undisclosed amount, a move that brings the clinical data structuring specialist under the umbrella of the IT service provider. The transaction, finalized this week, transfers full ownership of syndena’s technology and operations to x-tention, which will integrate the acquired platform into its existing healthcare portfolio.
Syndena develops software that converts unstructured clinical documents into structured, anonymised datasets suitable for real-world evidence generation. Its system runs on-premise within hospital IT environments, processing records continuously in the background without disrupting clinical workflows. The technology is designed to operate in full compliance with GDPR and, according to the company, adds no direct cost burden to healthcare providers. For life sciences partners and researchers, the platform offers access to cleaned, de-identified data for observational studies and patient care insights.
For x-tention, a provider of digital solutions for healthcare and public administration, the acquisition expands its capabilities in clinical data management. The company gains a proprietary tool that complements its existing offerings in hospital information systems and patient portals. Rather than building similar functionality in-house, x-tention now owns a proven solution that can be offered to its established customer base across German-speaking Europe.
The strategic rationale centers on the growing demand for real-world evidence in medical research and regulatory processes. By integrating syndena’s technology, x-tention can address hospitals seeking to monetize their data assets without compromising patient privacy or operational stability. The on-premise deployment model also aligns with the strict data sovereignty requirements common in European healthcare institutions.
Post-acquisition, syndena’s team is expected to continue operating from its current base, with product development focused on deepening integration with x-tention’s broader platform. The combined entity will target both hospital clients and pharmaceutical partners, leveraging syndena’s automated structuring to shorten the path from raw clinical notes to research-ready datasets. The deal positions x-tention to compete more directly in the emerging market for secondary use of clinical data, though the company has not disclosed specific growth targets or integration timelines.